Climb Bio's total assets for Q4 2025 were $167.74M, a decrease of -7.99% from the previous quarter. CLYM total liabilities were $7.27M for the fiscal quarter, a 37.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.